Bridgewater Associates »

Denali Therapeutics shares owned by Bridgewater Associates

Quarter-by-quarter ownership of Denali Therapeutics (DNLI) shares owned by Bridgewater Associates from 13F filings

Historical chart of Bridgewater Associates investment in Denali Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Denali Therapeutics held by Bridgewater Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Denali Therapeutics by Bridgewater Associates

Quarter filed Position value Share count Share price at filing
2022-12-31 $416k 15k 27.81
2022-06-30 $255k 8.7k 29.45
2022-03-31 $221k 6.9k 32.18